Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an enveloped RNA virus belonging to the genus Betacoronavirus, within the family Coronaviridae. It is the causative agent of the COVID-19 pandemic, which began in late 2019 and rapidly spread worldwide. For microbiology students, SARS-CoV-2 is particularly important not only because of its clinical impact, but because it provides a clear example of how viral structure, genome organization, and protein function interact to produce efficient host infection and transmission.

General Structure of the Virion

The SARS-CoV-2 virion is roughly spherical, typically 80–120 nanometres in diameter, although pleomorphism is observed. It is an enveloped virus, meaning that its outer layer is derived from host cell membranes. Embedded within this lipid envelope are viral proteins that define the virus’s ability to attach to and enter host cells.

Lipid Envelope and Origin

The viral envelope is acquired during the process of budding from intracellular membranes, particularly those of the endoplasmic reticulum–Golgi intermediate compartment (ERGIC). Because the envelope is derived from host membranes, it contains host-derived lipids, but its surface is dominated by viral glycoproteins that give the virus its characteristic structure and infectivity.

“Corona” Appearance and Spike Proteins

The name “coronavirus” comes from the crown-like appearance of the virion under electron microscopy. This morphology is caused by the spike (S) glycoproteins that protrude from the viral surface. These spikes are responsible for receptor binding and membrane fusion, making them the primary determinants of host specificity and infectivity.

Genomic Organization

SARS-CoV-2 has a positive-sense single-stranded RNA genome approximately 29.9 kilobases in length, making it one of the largest RNA virus genomes known. The genome functions directly as messenger RNA upon entry into the host cell, allowing immediate translation of viral proteins.

5′ and 3′ Untranslated Regions

At both ends of the genome are untranslated regions (UTRs) that play essential roles in replication and translation regulation. The 5′ UTR contains elements required for ribosome binding and initiation of translation, while the 3′ UTR contributes to RNA stability and genome replication efficiency.

Open Reading Frames (ORFs)

The genome contains multiple open reading frames. The first two-thirds of the genome encode ORF1a and ORF1b, which are translated into large polyproteins that are subsequently cleaved into non-structural proteins (nsps). The remaining third of the genome encodes structural proteins and accessory proteins involved in virion assembly and host interaction.

Non-Structural Proteins and Replication Machinery

The ORF1a/ORF1b region encodes a series of non-structural proteins (nsp1–nsp16) that form the viral replication–transcription complex. These proteins are essential for genome replication, transcription of subgenomic RNAs, and modulation of host cell processes.

RNA-Dependent RNA Polymerase

A central enzyme in viral replication is the RNA-dependent RNA polymerase (RdRp), encoded as nsp12. This enzyme synthesizes new RNA strands using the viral genome as a template. It functions in conjunction with cofactors such as nsp7 and nsp8, which enhance processivity.

Proteases and Polyprotein Processing

The viral polyproteins are cleaved by two main proteases: the main protease (Mpro, nsp5) and the papain-like protease (part of nsp3). These enzymes are essential for generating functional viral proteins and are important drug targets in antiviral therapy because inhibiting them disrupts the viral life cycle.

Proofreading and Replication Fidelity

Unlike many RNA viruses, coronaviruses possess a proofreading exonuclease (nsp14), which reduces replication errors. This feature contributes to the relatively large genome size and affects mutation rates, influencing viral evolution and the emergence of variants.

Structural Proteins of SARS-CoV-2

The virion contains four main structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N). Each plays a distinct role in virion assembly, structure, and infection.

Spike (S) Protein

The spike protein is a trimeric glycoprotein that mediates attachment to host cells. It binds to the angiotensin-converting enzyme 2 (ACE2) receptor on human cells, facilitating viral entry. The S protein is divided into two functional subunits: S1, responsible for receptor binding, and S2, responsible for membrane fusion.

Proteolytic cleavage at the S1/S2 boundary, often by host proteases such as furin, activates the spike protein for fusion. Structural changes in the spike protein are critical for viral entry, making it the primary target of neutralizing antibodies and vaccines, including mRNA-based platforms.

Membrane (M) Protein

The membrane protein is the most abundant structural protein in the virion. It plays a central role in shaping the viral envelope and coordinating assembly of new virions. M protein interacts with all other structural proteins, acting as an organizer of viral morphogenesis.

Envelope (E) Protein

The envelope protein is a small but functionally important component involved in virion assembly and release. It also functions as an ion channel (viroporin), influencing the intracellular environment during infection and contributing to virulence.

Nucleocapsid (N) Protein

The nucleocapsid protein binds to the viral RNA genome, forming a ribonucleoprotein complex that packages the genome into the virion. It also plays roles in RNA transcription, replication, and modulation of host cell responses. Because it is highly expressed, it is often used as a diagnostic marker in infection assays.

Accessory Proteins and Host Interaction

In addition to structural and replication proteins, SARS-CoV-2 encodes several accessory proteins that are not essential for replication in cell culture but contribute to immune evasion and pathogenesis in vivo.

Immune Evasion Strategies

Accessory proteins can interfere with host innate immune responses, particularly interferon signaling pathways. By dampening early immune detection, the virus enhances its ability to replicate before adaptive immunity is activated. This contributes to the asymptomatic or pre-symptomatic transmission characteristic of SARS-CoV-2.

Entry into Host Cells

Viral entry is initiated by binding of the spike protein to ACE2 receptors, which are expressed in various human tissues, including the respiratory tract. After receptor binding, the virus enters cells either through direct membrane fusion or endocytosis, depending on the availability of host proteases.

Tropism and ACE2 Distribution

The distribution of ACE2 receptors influences tissue tropism. High expression in the nasal epithelium, lungs, and gastrointestinal tract helps explain the respiratory and systemic manifestations of COVID-19. Understanding receptor distribution is essential for interpreting disease pathology.

Mutation and Viral Evolution

SARS-CoV-2 evolves through the accumulation of mutations in its RNA genome. While its proofreading mechanism reduces mutation rates compared to other RNA viruses, genetic variation still occurs, particularly under selective pressures such as host immunity and vaccination.

Variants of Concern

Certain mutations, especially in the spike protein, have led to the emergence of variants with altered transmissibility or immune evasion characteristics. These variants illustrate how small genetic changes can have significant epidemiological consequences.

Relevance to Microbiology and Biomedical Science

For microbiology students, SARS-CoV-2 serves as a model system for studying RNA virus biology, host–pathogen interactions, and molecular evolution. Its relatively large genome and complex protein repertoire provide insight into viral replication strategies that bridge basic virology and clinical disease.

The virus also highlights the importance of integrating structural biology, genomics, and immunology. Techniques such as cryo-electron microscopy, reverse genetics, and high-throughput sequencing have been essential in characterizing its structure and function.

Ultimately, SARS-CoV-2 demonstrates how viral structure and genome organization directly shape disease dynamics. Its study continues to inform vaccine design, antiviral drug development, and preparedness for future emerging pathogens.